Immunohistochemical	O	O
staining	O	O
was	O	O
positive	O	O
for	O	O
S	B-ENT	O
-	I-ENT	O
100	I-ENT	O
in	O	O
all	O	O
9	O	O
cases	O	O
stained	O	O
,	O	O
positive	O	O
for	O	O
HMB	B-ENT	B-ENT
-	I-ENT	O
45	I-ENT	O
in	O	O
9	O	O
(	O	O
90	O	O
%	O	O
)	O	O
of	O	O
10	O	O
,	O	O
and	O	O
negative	O	O
for	O	O
cytokeratin	B-ENT	O
in	O	O
all	O	O
9	O	O
cases	O	O
in	O	O
which	O	O
myxoid	O	O
melanoma	O	O
remained	O	O
in	O	O
the	O	O
block	O	O
after	O	O
previous	O	O
sections	O	O
.	O	O

Chloramphenicol	B-ENT	O
acetyltransferase	I-ENT	O
assays	O	O
examining	O	O
the	O	O
ability	O	O
of	O	O
IE86	B-ENT	B-ENT
to	O	O
repress	O	O
activity	O	O
from	O	O
the	O	O
HCMV	O	O
major	O	O
IE	B-ENT	B-ENT
promoter	I-ENT	I-ENT
or	O	O
activate	O	O
the	O	O
HCMV	B-ENT	B-ENT
early	I-ENT	O
promoter	I-ENT	I-ENT
for	O	O
the	O	O
2	O	O
.	O	O
2	O	O
-	O	O
kb	O	O
class	O	O
of	O	O
RNAs	O	O
demonstrated	O	O
the	O	O
functional	O	O
integrity	O	O
of	O	O
the	O	O
IE86	B-ENT	B-ENT
protein	I-ENT	I-ENT
.	O	O

A	O	O
new	O	O
DNA	B-ENT	O
repair	I-ENT	O
gene	I-ENT	O
from	O	O
Schizosaccharomyces	O	O
pombe	O	O
with	O	O
homology	O	O
to	O	O
RecA	B-ENT	B-ENT
was	O	O
identified	O	O
and	O	O
characterized	O	O
.	O	O

Our	O	O
study	O	O
also	O	O
demonstrated	O	O
significant	O	O
increases	O	O
in	O	O
the	O	O
number	O	O
of	O	O
larger	O	O
myelinated	O	O
fibers	O	O
crossing	O	O
the	O	O
repair	O	O
site	O	O
in	O	O
comparison	O	O
with	O	O
the	O	O
neonatal	O	O
and	O	O
adult	O	O
groups	O	O
(	O	O
p	O	O
<	O	O
0	O	O
.	O	O
04	O	O
)	O	O
.	O	O

Cloning	O	O
and	O	O
sequencing	O	O
of	O	O
the	O	O
upstream	O	O
region	O	O
of	O	O
pepX	B-ENT	B-ENT
revealed	O	O
the	O	O
presence	O	O
of	O	O
two	O	O
ORFs	O	O
of	O	O
360	O	O
and	O	O
1	O	O
,	O	O
338	O	O
bp	O	O
that	O	O
were	O	O
shown	O	O
to	O	O
be	O	O
able	O	O
to	O	O
encode	O	O
proteins	O	O
with	O	O
high	O	O
homology	O	O
to	O	O
GlnR	B-ENT	B-ENT
and	O	O
GlnA	B-ENT	B-ENT
proteins	I-ENT	I-ENT
,	O	O
respectively	O	O
.	O	O

Both	O	O
mutant	O	O
receptors	O	O
were	O	O
expressed	O	O
on	O	O
the	O	O
cell	O	O
surface	O	O
and	O	O
bound	O	O
insulin	B-ENT	O
normally	O	O
,	O	O
but	O	O
showed	O	O
markedly	O	O
impaired	O	O
autophosphorylation	O	O
in	O	O
response	O	O
to	O	O
insulin	B-ENT	O
.	O	O

Furthermore	O	O
,	O	O
analysis	O	O
of	O	O
the	O	O
E2	B-ENT	B-ENT
proteins	I-ENT	I-ENT
present	O	O
in	O	O
various	O	O
cell	O	O
lines	O	O
harboring	O	O
specific	O	O
BPV	O	O
-	O	O
1	O	O
mutants	O	O
,	O	O
including	O	O
the	O	O
2558	O	O
acceptor	O	O
mutant	O	O
,	O	O
proves	O	O
that	O	O
alternate	O	O
modes	O	O
of	O	O
E2	B-ENT	B-ENT
expression	O	O
exist	O	O
.	O	O

Molecular	O	O
modelling	O	O
suggested	O	O
that	O	O
the	O	O
tetramerization	O	O
domain	O	O
was	O	O
a	O	O
four	O	O
-	O	O
helix	O	O
bundle	O	O
,	O	O
stabilized	O	O
by	O	O
interactions	O	O
of	O	O
seven	O	O
conserved	O	O
aromatic	O	O
amino	O	O
acids	O	O
.	O	O

Hematology	O	O
problem	O	O
of	O	O
the	O	O
month	O	O
:	O	O
band	O	O
or	O	O
seg	O	O
?	O	O

PKA	B-ENT	O
phosphorylated	O	O
WT1	B-ENT	B-ENT
at	O	O
Ser	O	O
-	O	O
365	O	O
and	O	O
Ser	O	O
-	O	O
393	O	O
in	O	O
vitro	O	O
,	O	O
as	O	O
well	O	O
as	O	O
at	O	O
additional	O	O
sites	O	O
,	O	O
and	O	O
this	O	O
phosphorylation	O	O
abolished	O	O
the	O	O
DNA	O	O
-	O	O
binding	O	O
activity	O	O
of	O	O
WT1	B-ENT	B-ENT
in	O	O
vitro	O	O
.	O	O

ROCK	B-ENT	B-ENT
-	I-ENT	O
I	I-ENT	O
,	O	O
Kinectin	B-ENT	O
,	O	O
and	O	O
mDia2	B-ENT	B-ENT
can	O	O
bind	O	O
the	O	O
wild	O	O
type	O	O
forms	O	O
of	O	O
both	O	O
RhoA	B-ENT	B-ENT
and	O	O
Cdc42	B-ENT	I-ENT
in	O	O
a	O	O
GTP	O	O
-	O	O
dependent	O	O
manner	O	O
in	O	O
vitro	O	O
.	O	O

These	O	O
results	O	O
support	O	O
the	O	O
hypothesis	O	O
that	O	O
in	O	O
the	O	O
presence	O	O
of	O	O
tryptophan	O	O
the	O	O
ribosome	O	O
translating	O	O
tnaC	B-ENT	B-ENT
blocks	O	O
Rho	B-ENT	B-ENT
'	O	O
s	O	O
access	O	O
to	O	O
the	O	O
boxA	B-ENT	B-ENT
and	O	O
rut	B-ENT	O
sites	I-ENT	O
,	O	O
thereby	O	O
preventing	O	O
transcription	O	O
termination	O	O
.	O	O

Suppressors	O	O
of	O	O
defective	O	O
silencing	O	O
in	O	O
yeast	O	O
:	O	O
effects	O	O
on	O	O
transcriptional	O	O
repression	O	O
at	O	O
the	O	O
HMR	B-ENT	B-ENT
locus	I-ENT	I-ENT
,	O	O
cell	O	O
growth	O	O
and	O	O
telomere	O	O
structure	O	O
.	O	O

The	O	O
pJR	O	B-ENT
vectors	O	O
differ	O	O
among	O	O
them	O	O
in	O	O
:	O	O
(	O	O
a	O	O
)	O	O
the	O	O
selectable	O	O
marker	O	O
(	O	O
Saccharomyces	O	O
cerevisiae	O	O
LEU	B-ENT	B-ENT
2	I-ENT	O
gene	I-ENT	O
,	O	O
which	O	O
complements	O	O
S	B-ENT	O
.	I-ENT	O
pombe	I-ENT	O
leu1	I-ENT	I-ENT
-	I-ENT	I-ENT
gene	I-ENT	I-ENT
and	O	O
S	O	O
.	O	O
pombe	O	O
ura4	B-ENT	B-ENT
+	I-ENT	O
and	O	O
his3	B-ENT	O
+	I-ENT	O
genes	I-ENT	O
)	O	O
;	O	O
(	O	O
b	O	O
)	O	O
the	O	O
thiamine	O	O
-	O	O
repressible	O	O
nmt1	B-ENT	B-ENT
promoter	I-ENT	I-ENT
(	O	O
3X	O	O
,	O	O
41X	O	O
and	O	O
81X	O	O
with	O	O
extremely	O	O
high	O	O
,	O	O
moderate	O	O
or	O	O
low	O	O
transcription	O	O
efficiency	O	O
,	O	O
respectively	O	O
)	O	O
;	O	O
and	O	O
(	O	O
c	O	O
)	O	O
the	O	O
multiple	O	O
cloning	O	O
site	O	O
(	O	O
two	O	O
multiple	O	O
cloning	O	O
sites	O	O
,	O	O
with	O	O
12	O	O
restriction	O	O
sites	O	O
each	O	O
)	O	O
.	O	O

The	O	O
transcription	O	O
of	O	O
most	O	O
RP	B-ENT	B-ENT
genes	I-ENT	O
is	O	O
activated	O	O
by	O	O
two	O	O
Rap1p	B-ENT	O
binding	I-ENT	O
sites	I-ENT	O
,	O	O
250	O	O
to	O	O
400	O	O
bp	O	O
upstream	O	O
from	O	O
the	O	O
initiation	O	O
of	O	O
transcription	O	O
.	O	O

Cardiac	O	O
markers	O	O
troponin	B-ENT	O
T	I-ENT	B-ENT
,	O	O
CK	B-ENT	B-ENT
-	O	O
MB	B-ENT	O
mass	O	O
and	O	O
myoglobin	B-ENT	O
were	O	O
helpful	O	O
in	O	O
the	O	O
differential	O	O
diagnosis	O	O
of	O	O
chest	O	O
pain	O	O
,	O	O
even	O	O
when	O	O
the	O	O
ECG	O	O
was	O	O
unremarkable	O	O
or	O	O
nonspecific	O	O
.	O	O

Finally	O	O
,	O	O
in	O	O
situ	O	O
RNA	O	O
hybridization	O	O
studies	O	O
revealed	O	O
a	O	O
very	O	O
specific	O	O
pattern	O	O
of	O	O
EphA8	B-ENT	B-ENT
gene	I-ENT	O
expression	O	O
restricted	O	O
to	O	O
the	O	O
rostral	O	O
region	O	O
of	O	O
midbrain	O	O
tectum	O	O
during	O	O
embryonic	O	O
development	O	O
.	O	O

None	O	O
were	O	O
restricted	O	O
from	O	O
clinical	O	O
duties	O	O
,	O	O
were	O	O
given	O	O
varicella	B-ENT	O
-	I-ENT	O
zoster	I-ENT	O
immune	I-ENT	O
globulin	I-ENT	O
,	O	O
or	O	O
developed	O	O
disease	O	O
.	O	O

Positional	O	O
cloning	O	O
has	O	O
already	O	O
produced	O	O
the	O	O
sequences	O	O
of	O	O
more	O	O
than	O	O
70	O	O
human	O	O
genes	O	O
associated	O	O
with	O	O
specific	O	O
diseases	O	O
.	O	O

In	O	O
this	O	O
paper	O	O
,	O	O
we	O	O
demonstrate	O	O
that	O	O
binding	O	O
of	O	O
the	O	O
GA	B-ENT	B-ENT
-	I-ENT	O
binding	I-ENT	O
protein	I-ENT	I-ENT
(	O	O
GABP	B-ENT	B-ENT
)	O	O
to	O	O
ets	B-ENT	B-ENT
sequence	I-ENT	I-ENT
motifs	I-ENT	O
within	O	O
each	O	O
repeated	O	O
unit	O	O
is	O	O
required	O	O
for	O	O
transcriptional	O	O
activation	O	O
of	O	O
the	O	O
COXIV	B-ENT	B-ENT
promoter	I-ENT	I-ENT
.	O	O

These	O	O
activities	O	O
are	O	O
all	O	O
required	O	O
for	O	O
stimulation	O	O
of	O	O
cell	O	O
growth	O	O
by	O	O
middle	B-ENT	O
-	I-ENT	O
T	I-ENT	O
and	O	O
activate	O	O
members	O	O
of	O	O
the	O	O
MAP	B-ENT	B-ENT
kinase	I-ENT	I-ENT
family	I-ENT	O
.	O	O

HPLC	O	O
phosphopeptide	O	O
mapping	O	O
,	O	O
amino	O	O
acid	O	O
sequencing	O	O
,	O	O
and	O	O
site	O	O
-	O	O
directed	O	O
mutagenesis	O	O
determined	O	O
that	O	O
NCLK	B-ENT	B-ENT
phosphorylates	O	O
Ser	O	O
(	O	O
67	O	O
)	O	O
of	O	O
I	B-ENT	O
-	I-ENT	O
1	I-ENT	O
.	O	O

A	O	O
chaotropic	O	O
detergent	O	O
,	O	O
0	O	O
.	O	O
1	O	O
%	O	O
Nonidet	O	O
P	O	O
-	O	O
40	O	O
,	O	O
also	O	O
abolished	O	O
the	O	O
interaction	O	O
,	O	O
further	O	O
supporting	O	O
the	O	O
hydrophobic	O	O
nature	O	O
of	O	O
the	O	O
interaction	O	O
.	O	O

Genomic	O	O
and	O	O
cDNA	O	O
clones	O	O
homologous	O	O
to	O	O
the	O	O
yeast	O	O
GCN2	B-ENT	B-ENT
eIF	B-ENT	O
-	I-ENT	O
2alpha	I-ENT	O
kinase	O	I-ENT
(	O	O
yGCN2	O	B-ENT
)	O	O
were	O	O
isolated	O	O
from	O	O
Drosophila	O	O
melanogaster	O	O
.	O	O

Overexpression	O	O
of	O	O
RORgamma	B-ENT	O
has	O	O
been	O	O
shown	O	O
to	O	O
inhibit	O	O
T	B-ENT	O
cell	I-ENT	O
receptor	I-ENT	I-ENT
-	O	O
mediated	O	O
apoptosis	O	O
in	O	O
T	O	O
cell	O	O
hybridomas	O	O
and	O	O
to	O	O
repress	O	O
the	O	O
induction	O	O
of	O	O
Fas	B-ENT	O
-	I-ENT	O
ligand	I-ENT	O
and	O	O
interleukin	B-ENT	O
2	I-ENT	O
.	O	O

The	O	O
final	O	O
sigma54	B-ENT	O
-	I-ENT	O
dependent	I-ENT	O
DmpR	I-ENT	B-ENT
activator	I-ENT	O
regulates	O	O
transcription	O	O
of	O	O
the	O	O
dmp	B-ENT	B-ENT
operon	I-ENT	O
that	O	O
encodes	O	O
the	O	O
enzymes	O	O
for	O	O
catabolism	O	O
of	O	O
(	O	O
methyl	O	O
)	O	O
phenols	O	O
.	O	O

When	O	O
tethered	O	O
to	O	O
a	O	O
heterologous	O	O
DNA	O	O
-	O	O
binding	O	O
domain	O	O
,	O	O
PSU1	B-ENT	B-ENT
can	O	O
activate	O	O
transcription	O	O
on	O	O
its	O	O
own	O	O
.	O	O

The	O	O
sorption	O	O
mechanisms	O	O
changed	O	O
from	O	O
adsorption	O	O
to	O	O
partition	O	O
in	O	O
the	O	O
process	O	O
of	O	O
repetitious	O	O
sorption	O	O
.	O	O

Tyrosine	O	O
112	O	O
of	O	O
latent	B-ENT	O
membrane	I-ENT	I-ENT
protein	I-ENT	I-ENT
2A	I-ENT	I-ENT
is	O	O
essential	O	O
for	O	O
protein	B-ENT	O
tyrosine	I-ENT	I-ENT
kinase	I-ENT	I-ENT
loading	O	O
and	O	O
regulation	O	O
of	O	O
Epstein	O	O
-	O	O
Barr	O	O
virus	O	O
latency	O	O
.	O	O

Prognosis	O	O
of	O	O
asymptomatic	O	O
multiple	O	O
myeloma	O	O
.	O	O

In	O	O
contrast	O	O
to	O	O
behavioral	O	O
deviation	O	O
(	O	O
the	O	O
avoidance	O	O
conditioning	O	O
lost	O	O
)	O	O
,	O	O
the	O	O
haloperidol	O	O
intrastriatal	O	O
microinjections	O	O
did	O	O
not	O	O
affect	O	O
the	O	O
DA	O	B-ENT
synaptic	O	O
level	O	O
in	O	O
rostral	O	O
neostriatum	O	O
.	O	O

From	O	O
250	O	O
g	O	O
of	O	O
cells	O	O
,	O	O
we	O	O
isolated	O	O
1	O	O
mg	O	O
of	O	O
PDH	B-ENT	B-ENT
complex	I-ENT	O
with	O	O
a	O	O
specific	O	O
activity	O	O
of	O	O
12	O	O
.	O	O
6	O	O
U	O	O
/	O	O
mg	O	O
of	O	O
protein	O	O
.	O	O

Deletion	O	O
of	O	O
the	O	O
proximal	O	O
octanucleotide	O	O
motif	O	O
from	O	O
the	O	O
plasmid	O	O
containing	O	O
the	O	O
-	O	O
461	O	O
fragment	O	O
of	O	O
the	O	O
LPL	B-ENT	B-ENT
promoter	I-ENT	I-ENT
,	O	O
resulted	O	O
in	O	O
a	O	O
79	O	O
and	O	O
76	O	O
%	O	O
decrease	O	O
in	O	O
the	O	O
level	O	O
of	O	O
expression	O	O
in	O	O
transfected	O	O
3T3	O	O
-	O	O
L1	O	O
adipocytes	O	O
and	O	O
HepG2	O	O
hepatocytes	O	O
,	O	O
respectively	O	O
.	O	O

The	O	O
fragments	O	O
of	O	O
each	O	O
region	O	O
were	O	O
amplified	O	O
by	O	O
polymerase	O	O
chain	O	O
reaction	O	O
and	O	O
analyzed	O	O
by	O	O
gel	O	O
electrophoresis	O	O
to	O	O

